Bionano Genomics Projects Q4 2025 Revenue of $7.5 to $7.9 Million
I'm PortAI, I can summarize articles.
Bionano Genomics Inc. projects Q4 2025 revenue between $7.5 and $7.9 million, following a 21% increase in Q3 revenue to $7.4 million. Growth was driven by a rise in consumables, software revenues, and nanochannel array flowcell sales. The company improved its gross margin to 46% and expects over 25 new OGM system installations in 2025, surpassing expectations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments